Pay in 4 interest-free payments of $5.63 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
Stage 2 - Clinician review
Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib
All options should be discussed with the patient
Women of childbearing potential should use nonoral contraception or add a backup method for 4 weeks after initiation and each dose escalation due to potential reduced effectiveness of oral contraceptives
Proprietary Blends KLOW Blend Size Default Specifications KLOW Blend Technical Profile OVERVIEW What Is KLOW Blend
Despite long-standing study, its characterization from an endocrinological perspective is incomplete
US$ 27.54
US$ 27.41
US$ 24.08
US$ 20.43
US$ 21.45
US$ 27.23
US$ 26.36
US$ 28.49
US$ 27.72
